Pyridazinediones deliver potent, stable, targeted and efficacious antibody-drug conjugates (ADCs) with a controlled loading of 4 drugs per antibody (2017)
Attributed to:
Opening the door to novel antibody fragment-based therapeutics and diagnostics via a "dual click" strategy
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1039/c7ra00788d
Publication URI: http://dx.doi.org/10.1039/c7ra00788d
Type: Journal Article/Review
Parent Publication: RSC Advances
Issue: 15